Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$341K Buy
2,325
+2
+0.1% +$362 0.05% 140
2026
Q1
$342K Buy
2,323
+72
+3% +$11.7K 0.06% 137
2025
Q4
$439K Buy
2,251
+148
+7% +$35.2K 0.08% 116
2025
Q3
$591K Sell
2,103
-531
-20% -$135K 0.11% 108
2025
Q2
$576K Buy
2,634
+28
+1% +$4.52K 0.11% 103
2025
Q1
$364K Sell
2,606
-264
-9% -$43K 0.08% 114
2024
Q4
$478K Buy
2,870
+2
+0.1% +$355 0.1% 105
2024
Q3
$489K Buy
2,868
+1
+0% +$145 0.1% 109
2024
Q2
$405K Buy
2,867
+102
+4% +$12.7K 0.09% 112
2024
Q1
$347K Buy
2,765
+2
+0.1% +$229 0.08% 114
2023
Q4
$291K Sell
2,763
-83
-3% -$9.06K 0.07% 131
2023
Q3
$301K Buy
2,846
+2
+0.1% +$232 0.08% 126
2023
Q2
$339K Buy
+2,844
New +$294K 0.09% 114

Other funds holding ORCL

Essex LLC's ORCL Position: Q2 2026 in Review

Essex LLC increased its Oracle (ORCL) stake by 0.09% in Q2 2026, buying an estimated $362 and bringing the position to 2,325 shares worth $341K. The position accounts for 0.05% of the portfolio, ranked #140.

Essex LLC first reported a position in ORCL in Q2 2023 and has held it in 13 quarters since. The position peaked at $591K in Q3 2025. 1,681 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

  • Essex LLC held 2,325 shares of Oracle worth $341K as of Q2 2026.
  • Essex LLC bought 2 Oracle shares in Q2 2026, an estimated $362.
  • Oracle made up 0.05% of Essex LLC's portfolio in Q2 2026, its #140 holding.
  • Essex LLC first reported a position in Oracle in Q2 2023 and has held it in 13 quarters since.
  • Essex LLC's Oracle position peaked at $591K in Q3 2025.
  • 1,681 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on Essex LLC's 13F filing for Q2 2026, filed 24 Jul 2026.